Journals / Ankara Medical Journal / 2012 / Cilt: 12 Sayı: 1

Role and Benef its of Insulin Analogues in the Treatment of Diabetes Mellitus

İnsülin Analoglarının Diyabetes Mellitus Tedavisindeki Rolü ve Faydaları

Pages
22–31
Publication Date
2012-01-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Insulin analogues have an important role in medical treatment of diabetes mellitus.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Diabetes mellitus is an increasing health problem in the world and our country.
📊
Key Findings & Data:Medical nutrition, diet, exercise, patient education and medical treatment constitute major solution methods for this problem.
💡
Conclusion & Impact:Insulin analogues have an important role in medical treatment of diabetes mellitus.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Diyabetes Mellitus · İnsan insülini · Analog insülin

Abstract

Diabetes mellitus is an increasing health problem in the world and our country. Medical nutrition, diet, exercise, patient education and medical treatment constitute major solution methods for this problem. Insulin has a special place among choices of medical treatment. In this article, insulin analogues in treatment of diabetes mellitus were reviewed. When glycemic control, hypoglycemia side effect and patient compliance to treatment are considered, previous studies have shown that analogue insulins should be preferred to human insulin. Insulin analogues have an important role in medical treatment of diabetes mellitus.

Özet

Diyabetes Mellitus (DM) ülkemizde ve dünyada giderek artan bir sağlık problemidir. Tıbbi beslenme, diyet, egzersiz, hasta eğitimi ve medikal tedavi bu problemin çözüm yöntemleridir. Medikal tedavi seçenekleri içinde insülin tedavisi özel bir yer tutmaktadır. Bu yazıda diyabetes mellitus tedavisinde insülin analogları ele alınmıştır. Glisemik kontrol, hipoglisemi yan etkisi, tedavi uyumu kriter olarak alınırsa, İnsan insülini ile insülin analogları karşılaştırıldığında analog insülinlerin tercih edilmesi gerektiği yapılan çalışmalardan anlaşılmaktadır. İnsülin analogları diyabetes mellitusun medikal tedavisinde önemli bir yere sahiptir.

🔖

Cite This Article

ÇAKIR, B. (2012). Role and Benef its of Insulin Analogues in the Treatment of Diabetes Mellitus. Ankara Medical Journal, Cilt: 12 Sayı: 1, 22–31. https://ajindex.com/articles/981851

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. United Kingdom Prospective Diabetes Study Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet,1998, 352:854–865 2. United Kingdom Prospective Diabetes Study Group Intensive blood-glucose control with sulphonylureas or insülin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet,1998, 352:837–853 3. Ohkubo Y, Kishikawa H, Araki E et al. Intensive insülin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulindependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract, 1995, 28:103–117 4. Stratton IM, Adler AI, Neil HA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ,2000, 321:405–412 5. Gaede P, Vedel P, Larsen N et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med,2003, 348:383–393 6. Genuth S, Eastman R, Kahn R et al. Implications of the United kingdom prospective diabetes study. Diabetes Care,2003, 26:S28–S32 7. Chiasson JL. Acarbose for the prevention of diabetes, hypertension, and cardiovascular disease in subjects with impaired glucose tolerance: the Study to Prevent Non-Insulin-Dependent Diabetes Mellitus (STOP-NIDDM) Trial. Endocr Pract,2006, 12:25–30 8. Selvin E, Wattanakit K, Steffes MW, Coresh J, Sharrett AR. HbA1c and peripheral arterial disease in diabetes: the atherosclerosis risk in communities study. Diabetes Care,2006, 29:877–882 9. Kirkman MS, McCarren M, Shah J, Duckworth W, Abraira C. The association between metabolic control and prevalent macrovascular disease in Type 2 diabetes: the VA Cooperative Study in diabetes. J Diabetes Complications,2006, 20:75–80 10. Martin S, Schneider B, Heinemann L et al. Selfmonitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia,2006, 49:271–278 11. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care,2003, 26:S33–S50 12. IDF Global Guideline for Type 2 Diabetes, 2011. 13. Satman İ et al. TURDEP II results. Turkish Endocrinology and Metabolism Congress 2010 14. İlkova İ et al. IDMPS Turkey 3rd wave results – The profile of Type 2 DM patients and the treatment methods. National Diabetes Congress 201